IPO Pipeline Update: New Filings week ending 1.7.22
NEW FILINGS Company: Affinia Therapeutics Inc. Symbol: AFTX (Nasdaq) Description: They are a preclinical stage company pioneering a new class of rationally designed gene therapies with potentially curative benefit in patients with both rare and prevalent devastating diseases. Shares: TBD Price Range: TBD Trade Date: TBD Underwriters: Goldman Sachs, Jefferies, Piper Sandler Co-Manager(s): Chardan Link[…]
